{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T06:54:49Z","timestamp":1790060089532,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.healun.2022.01.008","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T18:26:17Z","timestamp":1642616777000},"page":"482-491","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["The impact of induction therapy on mortality and treated rejection in cardiac transplantation: A retrospective study"],"prefix":"10.1016","volume":"41","author":[{"given":"Lavanya","family":"Bellumkonda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4362-0720","authenticated-orcid":false,"given":"Evangelos K.","family":"Oikonomou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Maulion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Testani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0618-6750","authenticated-orcid":false,"given":"Jignesh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl s1","key":"10.1016\/j.healun.2022.01.008_bib0001","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/ajt.15676","article-title":"OPTN\/SRTR 2018 annual data report: heart","volume":"20","author":"Colvin","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2022.01.008_bib0002","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.healun.2007.05.002","article-title":"Lower risk of infectious deaths in cardiac transplant patients receiving basiliximab versus anti-thymocyte globulin as induction therapy","volume":"26","author":"Mattei","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.01.008_bib0003","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.healun.2006.03.024","article-title":"Ten-year follow-up of a prospective, randomized trial of BT563\/bb10 versus anti-thymocyte globulin as induction therapy after heart transplantation","volume":"25","author":"Bonaros","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.01.008_bib0004","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJM200003023420902","article-title":"Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody","volume":"342","author":"Beniaminovitz","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2022.01.008_bib0005","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1097\/01.tp.0000209924.00229.e5","article-title":"A randomized multicenter comparison of basiliximab and muromonab (OKT3) in heart transplantation: SIMCOR study","volume":"81","author":"Segovia","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.01.008_bib0006","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.healun.2011.01.716","article-title":"Antithymocyte globulin induction therapy for adult heart transplantation: a UK national study","volume":"30","author":"Emin","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.01.008_bib0007","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.transproceed.2004.12.135","article-title":"Daclizumab is associated with decreased rejection and no increased mortality in cardiac transplant patients receiving MMF, cyclosporine, and corticosteroids","volume":"37","author":"Kobashigawa","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2022.01.008_bib0008","doi-asserted-by":"crossref","first-page":"422","DOI":"10.12659\/AOT.907984","article-title":"Outcomes of induction therapy with rabbit anti-thymocyte globulin in heart transplant recipients: a single center retrospective cohort study","volume":"23","author":"Jarmi","year":"2018","journal-title":"Ann Transplant"},{"key":"10.1016\/j.healun.2022.01.008_bib0009","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/ctr.12469","article-title":"Impact of induction immunosuppression on survival in heart transplant recipients: a contemporary analysis of agents","volume":"29","author":"Whitson","year":"2015","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2022.01.008_bib0010","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.healun.2007.01.006","article-title":"Basiliximab and rabbit anti-thymocyte globulin for prophylaxis of acute rejection after heart transplantation: a non-inferiority trial","volume":"26","author":"Carrier","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.01.008_bib0011","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/01.tp.0000168153.50774.30","article-title":"Induction therapy for pediatric and adult heart transplantation: comparison between OKT3 and daclizumab","volume":"80","author":"Chin","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.01.008_bib0012","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.jtcvs.2011.07.019","article-title":"Effect of sensitization in US heart transplant recipients bridged with a ventricular assist device: update in a modern cohort","volume":"142","author":"Arnaoutakis","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2022.01.008_bib0013","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cardfail.2020.07.012","article-title":"Differential impact of Class I and Class II panel reactive antibodies on post-heart transplant outcomes","volume":"27","author":"Ivey-Miranda","year":"2021","journal-title":"J Card Fail"},{"key":"10.1016\/j.healun.2022.01.008_bib0014","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1097\/00007890-200005150-00026","article-title":"Improved long-term results with thymoglobuline induction therapy after cardiac transplantation: a comparison of two different rabbit-antithymocyte globulines","volume":"69","author":"Zuckermann","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.01.008_bib0015","first-page":"1","article-title":"Comparison of basiliximab and anti-thymocyte globulin as induction therapy in pediatric heart transplantation: a survival analysis","volume":"5","author":"Ansari","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.healun.2022.01.008_bib0016","doi-asserted-by":"crossref","first-page":"e13190","DOI":"10.1111\/petr.13190","article-title":"Comparison of basiliximab vs antithymocyte globulin for induction in pediatric heart transplant recipients: an analysis of the International Society for Heart and Lung Transplantation database","volume":"22","author":"Butts","year":"2018","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2022.01.008_bib0017","doi-asserted-by":"crossref","first-page":"322","DOI":"10.12659\/AOT.908243","article-title":"A review of induction with rabbit antithymocyte globulin in pediatric heart transplant recipients","volume":"23","author":"Schweiger","year":"2018","journal-title":"Ann Transplant"},{"key":"10.1016\/j.healun.2022.01.008_bib0018","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/01.TP.0000045223.66828.FA","article-title":"Rabbit antithymocyte globulin as induction immunotherapy in pediatric heart transplantation","volume":"75","author":"Di Filippo","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.01.008_bib0019","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.healun.2004.04.014","article-title":"Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat)","volume":"24","author":"Koch","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.01.008_bib0020","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1097\/00007890-200204270-00026","article-title":"CD3 monitoring of antithymocyte globulin therapy in thoracic organ transplantation","volume":"73","author":"Krasinskas","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.01.008_bib0021","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJM199012203232502","article-title":"Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients","volume":"323","author":"Swinnen","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2022.01.008_bib0022","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1093\/ndt\/gfp425","article-title":"Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma","volume":"25","author":"Ingvar","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.healun.2022.01.008_bib0023","doi-asserted-by":"crossref","first-page":"e13769","DOI":"10.1111\/ctr.13769","article-title":"Recent advances in the role of mammalian target of rapamycin inhibitors on cardiac allograft vasculopathy","volume":"34","author":"Bellumkonda","year":"2020","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2022.01.008_bib0024","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.healun.2008.02.016","article-title":"Delayed onset of cardiac allograft vasculopathy by induction therapy using anti-thymocyte globulin","volume":"27","author":"Zhang","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.01.008_bib0025","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/S0041-1345(02)03103-2","article-title":"Low incidence of graft arteriosclerosis after cardiac transplantation: risk factor analysis for patients with induction therapy","volume":"34","author":"Zuckermann","year":"2002","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2022.01.008_bib0026","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002252","article-title":"Induction therapy with antithymocyte globulin in patients undergoing cardiac transplantation is associated with decreased coronary plaque progression as assessed by intravascular ultrasound","volume":"9","author":"Azarbal","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.healun.2022.01.008_bib0027","doi-asserted-by":"crossref","first-page":"E450","DOI":"10.1111\/ctr.12021","article-title":"The role of Thymoglobulin induction in kidney transplantation: an update","volume":"26","author":"Mourad","year":"2012","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2022.01.008_bib0028","doi-asserted-by":"crossref","first-page":"e13366","DOI":"10.1111\/petr.13366","article-title":"Comparison of 10-year graft failure rates after induction with basiliximab or anti-thymocyte globulin in pediatric heart transplant recipients-The influence of race","volume":"23","author":"Carlo","year":"2019","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.healun.2022.01.008_bib0029","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1097\/01.tp.0000244063.05338.27","article-title":"B-cell activity of polyclonal antithymocyte globulins","volume":"82","author":"Zand","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.01.008_bib0030","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/01.TP.0000130179.18176.3D","article-title":"Antithymocyte globulin induction allows a prolonged delay in the initiation of cyclosporine in heart transplant patients with postoperative renal dysfunction","volume":"78","author":"Cantarovich","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2022.01.008_bib0031","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/MAT.0000000000001119","article-title":"Impact of induction immunosuppression on post-transplant outcomes of patients bridged with contemporary left ventricular assist devices","volume":"66","author":"Truby","year":"2020","journal-title":"ASAIO J"},{"key":"10.1016\/j.healun.2022.01.008_bib0032","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.healun.2006.09.002","article-title":"Basiliximab versus rabbit anti-thymocyte globulin for induction therapy in patients after heart transplantation","volume":"25","author":"Flaman","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2022.01.008_bib0033","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.healun.2015.04.001","article-title":"Induction with anti-thymocyte globulin in heart transplantation is associated with better long-term survival compared with basiliximab","volume":"34","author":"Ansari","year":"2015","journal-title":"J Heart Lung Transplant"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249822000067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249822000067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:42:32Z","timestamp":1760949752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249822000067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S1053249822000067"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2022.01.008","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of induction therapy on mortality and treated rejection in cardiac transplantation: A retrospective study","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2022.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Society for Heart and Lung Transplantation. All rights reserved.","name":"copyright","label":"Copyright"}]}}